NOVO.B.DK

247.5

+0.22%↑

GMAB.DK

1,719

+0.7%↑

HLUNB.DK

37.64

+0.75%↑

AMBUB.DK

71.85

-0.14%↓

ZEAL.DK

280.9

+4.19%↑

NOVO.B.DK

247.5

+0.22%↑

GMAB.DK

1,719

+0.7%↑

HLUNB.DK

37.64

+0.75%↑

AMBUB.DK

71.85

-0.14%↓

ZEAL.DK

280.9

+4.19%↑

NOVO.B.DK

247.5

+0.22%↑

GMAB.DK

1,719

+0.7%↑

HLUNB.DK

37.64

+0.75%↑

AMBUB.DK

71.85

-0.14%↓

ZEAL.DK

280.9

+4.19%↑

NOVO.B.DK

247.5

+0.22%↑

GMAB.DK

1,719

+0.7%↑

HLUNB.DK

37.64

+0.75%↑

AMBUB.DK

71.85

-0.14%↓

ZEAL.DK

280.9

+4.19%↑

NOVO.B.DK

247.5

+0.22%↑

GMAB.DK

1,719

+0.7%↑

HLUNB.DK

37.64

+0.75%↑

AMBUB.DK

71.85

-0.14%↓

ZEAL.DK

280.9

+4.19%↑

Search

Coloplast A-S (Class B)

Chiusa

451.6 0.92

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

445.8

Massimo

453.3

Metriche Chiave

By Trading Economics

Entrata

522M

1.4B

Vendite

83M

7B

P/E

Media del settore

25.385

61.417

EPS

6.32

Rendimento da dividendi

4.98

Margine di Profitto

19.835

Dipendenti

16,983

EBITDA

309M

2.3B

Raccomandazioni

By TipRanks

Raccomandazioni

Neutrale

Previsioni per 12 mesi

+11.86% upside

Dividendi

By Dow Jones

Rendimento da dividendi

Media del settore

4.98%

2.40%

Utili prossimi

12 mag 2026

Prossima data del Dividendo

20 mag 2026

Prossima data del' Ex Dividendo

18 mag 2026

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

-17B

101B

Apertura precedente

450.68

Chiusura precedente

451.6

Coloplast A-S (Class B) Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

15 mar 2026, 21:14 UTC

Principali Notizie su Eventi

Week Ahead for FX, Bonds: Central Bank Decisions -2-

15 mar 2026, 21:14 UTC

Principali Notizie su Eventi

Week Ahead for FX, Bonds: Central Bank Decisions in Focus After Jump in Energy Prices

16 mar 2026, 00:00 UTC

Principali Notizie su Eventi

Hack on U.S. Medical Company Shows Reach of Iran's Cyber Capabilities -- WSJ

15 mar 2026, 23:45 UTC

Discorsi di Mercato

Nikkei May Decline on Concerns About Prolonged Middle East Conflict -- Market Talk

15 mar 2026, 23:44 UTC

Discorsi di Mercato
Principali Notizie su Eventi

Gold Falls as Rising Energy Prices Exacerbate Inflation Worries -- Market Talk

15 mar 2026, 23:35 UTC

Discorsi di Mercato
Principali Notizie su Eventi

Oil Futures Rise on Supply Disruption Concerns -- Market Talk

15 mar 2026, 23:00 UTC

Acquisizioni, Fusioni, Takeovers

Micron Completes Acquisition Of PSMC's Tongluo P5 Site In Taiwan >MU

15 mar 2026, 22:37 UTC

Discorsi di Mercato

March Rate Hike Would Distance RBA From Government's May Budget -- Market Talk

15 mar 2026, 22:18 UTC

Discorsi di Mercato

RBA's Likely Hike Motivated By Inflation, Not Middle East -- Market Talk

15 mar 2026, 22:14 UTC

Utili

Genscript Biotech 2025 Adj Net $230.35M Vs. Adj Net $59.83M>1548.HK

15 mar 2026, 22:14 UTC

Utili

Genscript Biotech: 2025 Loss Due to High Base Effect, One-off Unrealized Gains Seen Last Year >1548.HK

15 mar 2026, 22:14 UTC

Utili

Genscript Biotech 2025 Rev $959.53M Vs. $594.49M >1548.HK

15 mar 2026, 22:14 UTC

Utili

Genscript Biotech 2025 Loss $532.83M Vs. Net $2.96B >1548.HK

15 mar 2026, 22:14 UTC

Utili

Genscript Biotech: 2025 Rev Supported by Substantial Increase in License Revenue>1548.HK

15 mar 2026, 22:00 UTC

Principali Notizie su Eventi

Oil Industry Warns Trump Administration Energy Crisis Will Likely Worsen -- WSJ

15 mar 2026, 22:00 UTC

Principali Notizie su Eventi

Oil Industry Warns Trump Administration Energy Crisis Will Likely Worsen -- WSJ

15 mar 2026, 03:00 UTC

Principali Notizie su Eventi

For Xi, Iran War Reinforces View of U.S. as Dangerous Superpower -- WSJ

14 mar 2026, 15:00 UTC

Principali Notizie su Eventi

Iran War Delivers Windfall to America's Oil Country -- WSJ

14 mar 2026, 02:03 UTC

Utili

This Copper Stock Is Worth Mining for Profits -- Barrons.com

14 mar 2026, 01:32 UTC

Acquisizioni, Fusioni, Takeovers

Bill Ackman's Pershing Square IPO Is Back On -- Barrons.com

14 mar 2026, 00:29 UTC

Acquisizioni, Fusioni, Takeovers

13D Filings -- Barrons.com

13 mar 2026, 22:27 UTC

Discorsi di Mercato
Principali Notizie su Eventi

Bahrain Faces Uncertainty But Has Support Amid War, S&P Says -- Market Talk

13 mar 2026, 22:13 UTC

Discorsi di Mercato
Principali Notizie su Eventi

Saudi Arabia Seen as Able to Weather Iran Conflict, S&P Says -- Market Talk

13 mar 2026, 22:04 UTC

Discorsi di Mercato
Principali Notizie su Eventi

Emirate of RAK Outlook Stable Despite Iran War, S&P Says -- Market Talk

13 mar 2026, 22:00 UTC

Acquisizioni, Fusioni, Takeovers

Trump Administration Set to Receive $10 Billion Fee for Brokering TikTok Deal -- WSJ

13 mar 2026, 20:50 UTC

Discorsi di Mercato

Health Care Roundup: Market Talk

13 mar 2026, 20:50 UTC

Discorsi di Mercato
Principali Notizie su Eventi

Financial Services Roundup: Market Talk

13 mar 2026, 20:02 UTC

Discorsi di Mercato

Canada Rate Hike in 2026 Would Mark 'Extraordinarily Bad' Policy -- Market Talk

13 mar 2026, 19:50 UTC

Discorsi di Mercato
Principali Notizie su Eventi

Oil Posts Weekly Gains As Middle East Conflict Drags On -- Market Talk

13 mar 2026, 19:35 UTC

Principali Notizie su Eventi

Oil Prices Hover Near $100. India Asks Iran to Allow 23 Tankers Through Strait of Hormuz. -- Barrons.com

Confronto tra pari

Modifica del prezzo

Coloplast A-S (Class B) Previsione

Obiettivo di Prezzo

By TipRanks

11.86% in crescita

Previsioni per 12 mesi

Media 901.38 DKK  11.86%

Alto 1,056 DKK

Basso 720 DKK

Basato su 8 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Coloplast A-S (Class B) - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Neutrale

8 ratings

2

Acquista

4

Mantieni

2

Vendi

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Coloplast A-S (Class B)

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen Plus, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include cleansers, moisturizers, skin protectants, antifungal products, and hand cleansers, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.
help-icon Live chat